eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Editorials

West Nile virus: is there a message for Australia?

John S Mackenzie, David W Smith and Roy A Hall
MJA 2003 178 (1): 5-6

The US strain of West Nile virus could enter Australia, but we may be protected by the already present Kunjin virus

Australia needs to consider the implications of the recent emergence and spread of West Nile virus in the United States, including the possibility of its spread to Australia. This development also raises questions about Kunjin virus, a subtype of West Nile virus, which already occurs widely in Australia.

West Nile virus, a mosquito-borne flavivirus, was known to have a wide geographic range, extending from Africa through the Middle East to southern and eastern Europe and western Asia. The initial outbreak in New York city and adjacent counties in August 1999 resulted in 62 human infections and seven deaths of elderly patients.1,2 Genetic evidence suggests that the virus came from the Middle East. Over the next three years, it spread rapidly in the US, first in the north-east and then more widely, causing disease and deaths in humans, horses and birds.3 Birds, especially crows, were found to be responsible for both spread and maintenance of the virus in a natural cycle with culicine mosquitoes.3,4 By late November 2002, the virus had been detected in 43 states spanning the mainland US, with 3735 reported clinical cases and 215 deaths, almost all among the elderly.5 The virus had also spread to five provinces in Canada, with around 140 cases and two deaths. The speed of its spread was undoubtedly due to the presence of competent mosquito species and a large number of susceptible birds, and especially to a greatly increased propensity to spread in a virgin ecosystem.

Before 1996, West Nile virus was known to cause high fever, chills, malaise, headache, backache, arthralgia, myalgia and retro-orbital pain, and, in about 50% of cases, a maculopapular rash,6 but neurological symptoms were uncommon. Since then, severe neurological illness, including encephalitis and meningitis, has been reported more frequently,6,7 together with an acute flaccid paralysis syndrome.6,8 Fatalities have generally been in the elderly. Although human acquisition is nearly always through the bite of an infected mosquito, unusual modes of transmission via organ transplantation,9 blood transfusion9,10 and possibly breastfeeding11 have recently been described in the US.

West Nile virus is closely related antigenically and genetically to other members of the Japanese encephalitis serological group of flaviviruses, including Japanese encephalitis, Murray Valley encephalitis (MVE), and St Louis encephalitis viruses, and is almost identical genetically and immunologically to Kunjin virus.12

Kunjin virus, reclassified as a subtype of West Nile virus in 2000, is the most common flavivirus in Australia, occurring widely across northern Australia. Most infections with this virus are asymptomatic, but it causes occasional, mild febrile illness, similar to that traditionally described for West Nile virus, and rare cases of non-fatal encephalitis.13 It is closely related genetically to the West Nile strain in North America,1,2 both being members of West Nile lineage 1. However, unlike Kunjin virus, some recently isolated members of West Nile lineage 1 are known to cause fatal encephalitis in elderly patients,3,6,7 fatal disease in wild birds (in North America)3,14 and domestic geese (in Israel),15 and severe epizootics in horses, with significant mortality.7,13,14 In addition, recent experimental evidence has shown that the New York strain of West Nile virus is considerably more neuroinvasive than Kunjin virus.16

Could Kunjin virus mutate to be as virulent as recent West Nile strains seen in Europe and the US? Kunjin virus has been in our ecological system for many years without any apparent increase in virulence. Several mutations may be required to increase virulence substantially, and there seems little pressure to select for such mutations.

Alternatively, could a more pathogenic strain of West Nile virus spread to Australia and, if it did, would it be able to establish itself in competition with Kunjin virus? West Nile virus has been isolated in Sarawak, Malaysia, and is endemic in western India; thus, it could conceivably spread slowly through the region. The virus is believed to have reached New York through carriage on an aircraft of an infected mosquito or an infected traveller with sufficient viraemia to infect a mosquito on arrival in the US. Similar mechanisms could allow its importation into Australia from the US, Europe or Africa. Although current disinsection procedures for aircraft are believed to minimise the first possibility, there is concern that an infected human traveller arriving in Australia might have sufficient viraemia to infect Australian mosquitoes. More information is urgently needed on viraemia levels during infection so that this risk can be properly assessed.

Other routes of entry seem less likely. Although a horse infected with West Nile virus was recently imported into Australia from North America, viraemia levels in horses are believed to be insufficient to infect mosquitoes. Introduction of virus through migratory birds is doubtful because of the route and length of migration. Even if West Nile virus is introduced into Australia, it would have to compete with Kunjin virus for vertebrate hosts and vectors. Experience with other members of the Japanese encephalitis serogroup of flaviviruses suggests that they do not interfere with each other's ability to spread,12 despite the induction of cross-reacting antibodies. Thus, West Nile and Japanese encephalitis viruses coexist in western India, and MVE and Kunjin viruses coexist in Australia, while West Nile and St Louis encephalitis viruses appear to coexist in North America, and Japanese encephalitis and MVE viruses appear to coexist in Papua New Guinea. However, antibodies to Kunjin virus neutralise West Nile virus (and vice versa), and Kunjin virus is widely distributed over much of Australia, so it may prove more difficult for West Nile virus to find the susceptible vertebrate hosts it needs to become established or to spread rapidly.

There is no treatment or vaccine available for West Nile infection, but people with prior exposure to Kunjin virus should be protected. Similarly, those exposed to other members of the Japanese encephalitis serological group, especially Japanese encephalitis and MVE viruses, may have limited protection against West Nile disease. The current Japanese encephalitis vaccine is unlikely to protect, although more research is needed to confirm this.17,18

Finally, could Japanese encephalitis virus spread in Australia as West Nile virus has done in the US? Japanese encephalitis virus has occurred in the Torres Strait of northern Australia nearly every year since 1995, and entered the Australian mainland in 1998.19,20 As Australia has the appropriate mosquitoes and avian and porcine vertebrate hosts for natural transmission cycles,20 it is likely that Japanese encephalitis virus will eventually become established here. However, the narrow range of bird species used by Japanese encephalitis virus as maintenance hosts (generally herons and egrets), the need for pigs as amplifier hosts, as well as the Australian ecosystem, climate and arid interior, would suggest that Japanese encephalitis virus is unlikely to match the spread of West Nile virus in North America.

Migratory birds, wind-blown insects and rapid air transport of infected humans, animals and insects could all bring exotic pathogens into Australia. Identifying potential threats, maintaining aircraft disinsection and mosquito surveillance around major airports, as well as good internal surveillance, are important parts of the protection of human and animal health in this country.

  1. Jia XY, Briese T, Jordan I, et al. Genetic analysis of the West Nile New York encephalitis virus. Lancet 1999; 354: 1971-1972. <PubMed>
  2. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern U.S. Science 1999; 286: 2333-2337. <PubMed>
  3. Campbell GL, Marfinn AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002; 2: 519-529. <PubMed>
  4. Roehrig JT, Layton M, Smith P, Campbell GL, et al. The emergence of West Nile virus in North America: ecology, epidemiology and surveillance. Curr Top Microbiol Immunol 2002; 267: 223-240. <PubMed>
  5. United States Department of Health and Human Services, Centers for Disease Control and and Prevention. West Nile virus update current case count. Available at http://www.cdc.gov/od/oc/media/wncount.htm Accessed Nov 2002.
  6. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002; 267: 171-194. <PubMed>
  7. Murgue B, Zeller H, Deubel V. The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr Top Microbiol Immunol 2002; 267: 196-221.
  8. Accute flaccid paralysis syndrome associated with West Nile virus infection — Mississippi and Louisiana, July-August 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 825-828. <PubMed>
  9. Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion. MMWR Morb Mortal Wkly Rep 2002; 51: 833-836. <PubMed>
  10. Investigations of West Nile virus infections in recipients of blood transfusions. MMWR Morb Mortal Wkly Rep 2002; 51: 973-974. <PubMed>
  11. Possible West Nile virus transmission to an infant through breast-feeding — Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 877-878. <PubMed>
  12. Mackenzie JS, Barrett ADT, Deubel V. The Japanese encephalitis serological group of flaviviruses: a brief introduction to the group. Curr Top Microbiol Immunol 2002; 267: 1-10. <PubMed>
  13. Hall RA, Broom AK, Smith DW, Mackenzie JS. The ecology and epidemiology of Kunjin virus. Curr Top Microbiol Immunol 2002; 267: 253-269. <PubMed>
  14. McLean RG, Ubico SR, Bourne D, Komar N. West Nile virus in livestock and wildlife. Curr Top Microbiol Immunol 2002; 267: 272-308.
  15. Malkinson M, Banet C. The role of birds in the ecology of West Nile virus in Europe and Africa. Curr Top Microbiol Immunol 2002; 267: 309-322. <PubMed>
  16. Beasley DW, Li L, Suderman MT, Barrett AD. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002; 296: 17-23. <PubMed>
  17. Kanesa-Thasan N, Putnak JR, Mangiafico JA, et al. Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg 2002; 66: 115-116. <PubMed>
  18. Monath TP. Jennerian vaccination against West Nile [editorial]. Am J Trop Med Hyg 2002; 66: 113-114. <PubMed>
  19. Hanna JN, Ritchie SA, Phillips DA, et al. Japanese encephalitis in North Queensland, 1998. Med J Aust 1999; 170: 533-536. <PubMed>
  20. Mackenzie JS, Johansen CA, Ritchie SA, et al. Japanese encephalitis as an emerging virus: the emergence of and spread of Japanese encephalitis virus in Australasia. Curr Top Microbiol Immunol 2002; 267: 49-73. <PubMed>

(Received 20 Sep 2002, accepted 8 Nov 2002)

School of Molecular and Microbial Sciences, University of Queensland, Brisbane, QLD.

John S Mackenzie, BSc, PhD, Professor of Microbiology; Roy A Hall, BSc, PhD, Senior Research Officer.

Division of Microbiology and Infectious Diseases, Western Australian Centre for Pathology and Medical Research, Nedlands, WA.

David W Smith, FRCPA, Clinical Director.

Reprints: Professor John S Mackenzie, School of Molecular and Microbial Sciences, University of Queensland, Brisbane, QLD 4072. John.MackenzieATuq.edu.au

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  

©The Medical Journal of Australia 2003 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377